Study how RIR affects outcomes after heart stent procedures
Part of Heart & circulation clinical trials.
This trial looks at a factor called RIR and whether it changes health outcomes for people with coronary heart disease who get a PCI (a heart stent procedure) while in the hospital. It may help doctors understand who benefits and how to improve care after stenting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 80 years old (no matter your sex).
- You are hospitalized with coronary heart disease and are scheduled to get PCI (heart stent procedure).
- You can understand the study and voluntarily sign the consent form.
- You complete the planned PCI while you’re in the hospital.
- You did not have another procedure or surgery for your heart within the past 3 months.
- You don’t have uncontrolled infections or certain immune/autoimmune or cancer conditions being screened for.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with coronary heart disease who get PCI (a procedure to open clogged heart arteries, often with a stent) and looks at their prognosis afterward. It may help researchers understand what affects recovery and outcomes after the procedure.
This study follows people who already had a stent put in (PCI) using a special imaging test (NIRS-IVUS) to look at heart outcomes over time. If you agreed and can attend follow-up visits, this registry may help doctors better understand how this imaging-guided approach performs.
This trial is looking at whether a blood test can help doctors choose the best treatment for people with heart disease who are getting stents. It may help make treatment more personal and effective.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
This study tests whether giving a drug called nicorandil directly into the heart artery just before placing a stent can help keep blood flow normal and reduce complications after the procedure.
This trial looks at whether stronger cholesterol-lowering medicine can reduce the risk of future heart problems in people who already have a stent. It focuses on people who still have other mildly narrowed spots in their arteries.
Hear when a new hsCRP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.